Longitudinal Changes in Plasma GFAP and Their Potential Role in Alzheimer's Disease Progression

Abstract

Background: Brain amyloid deposition may affect the relationship between plasma glial fibrillary acidic protein (GFAP), a marker of astrocytic activation, and cognitive decline, but its role in modulating cognitive outcomes remains unclear.

The paper